Optimi Health Corp.

Nasdaq: OPTH

Day 143 public/EMERGING/IPO May 20, 2026/Pharmaceutical Preparations

$4.02

▼ 0.07 (-1.59%)

LIVE

updated 16h ago

Intelligence Core

MONITORING

No new filings in 72 h · watching for the next event

Current missionDurability · Day 91–180

Determine whether the company is establishing durable public-market positioning.

Focus

Sustained fundamentalsOwnershipValuationRecurring catalysts

CAUTIOUSFORMING THESIS…Intelligence score DERIVED

/ 100

Confidence45%

CURRENT THESIS INTERPRETED

Optimi Health Corp. is an emerging clinical-stage pharmaceutical company public for 143 days with no XBRL fundamentals or 10-Q/10-K filings yet available. Institutional interest is present with 3 Schedule 13D/13G filings, but momentum is neutral to slightly negative with recent minor price weakness.

Momentum

Price · since IPOLIVE

Yahoo · 99 pts

H $6.08L $4.01Last $4.02

Current ThesisINTERPRETEDLIVE

Why

+Institutional backing evidenced by 3 Schedule 13D/13G disclosures
+Active SEC filing schedule including recent 6-K and 424B3 filings following an F-1 registration

Risks

−Absence of XBRL fundamental financial data or periodic 10-Q/10-K reports
−Clinical-stage sector operational and developmental risks
−Thin fundamental evidence base due to early public tenure of 143 days

Catalysts

→Future release of foundational 10-K or 10-Q financial filings
→Clinical pipeline updates and regulatory progress disclosed via 6-K filings

Current Thesis

Company Web Research · Official DomainVIEW ONLY

https://optimi.net

VIEW-ONLY

Visit

LIVE · SANDBOXED

Resolving official website…

Research EnvironmentLIVE

Research environment · $OPTHSEC · market · news

22 evidence items|newest evidence 2d ago

Core activity · newest firstreal events · view-only

0s agoSCOREDERIVEDIntelligence score 59/100 recomputed from 4 rule-based signals.via Deterministic scoreDERIVED

0s agoSTATECore MONITORING · No new filings in 72 h · watching for the next event. Mission: Durability.via Intelligence Core

16h agoOBSERVATIONVERIFIEDLast price $4.02 · -1.59% on the day.via Finnhub quoteVERIFIED

2d agoEVIDENCEOptimi Health to Present at the ThinkEquity Conferencevia Yahoo · tier 3, cross-check Oct 7, 2026EVIDENCEVERIFIEDForm 6-K filed · FORM 6-K.via SEC EDGARVERIFIED Oct 5, 2026EVIDENCEVERIFIEDForm SCHEDULE 13G/A filed.via SEC EDGARVERIFIED 11d agoEVIDENCEOptimi Health Appoints Melanie Pump to Board of Directorsvia Yahoo · tier 3, cross-check Sep 29, 2026EVIDENCEVERIFIEDForm 6-K filed · FORM 6-K.via SEC EDGARVERIFIED 16d agoEVIDENCEOptimi Health Completes Psilocybin Production for Phase 2 MDD Trialvia Yahoo · tier 3, cross-check Sep 23, 2026EVIDENCEVERIFIEDForm 6-K filed · FORM 6-K.via SEC EDGARVERIFIED Sep 22, 2026EVIDENCEVERIFIEDForm 6-K filed · FORM 6-K.via SEC EDGARVERIFIED

Evidence · SEC filing timelineVERIFIED

Filed	Form	Document	Source
2026-10-07	6-K	FORM 6-K	SEC ↗
2026-10-05	SCHEDULE 13G/A	Optimi Health Corp.	SEC ↗
2026-09-29	6-K	FORM 6-K	SEC ↗
2026-09-23	6-K	FORM 6-K	SEC ↗
2026-09-22	6-K	FORM 6-K	SEC ↗

VERIFIEDfrom a primary sourceDERIVEDcomputed by rulesINTERPRETEDreasoned from evidence

Assembled 0s ago · every panel labelled live or simulated · no fabricated metrics